Recognition of Excellence in Gene Therapy
Professor Mimoun Azzouz, a prominent Moroccan academic and head of the Gene Therapy Innovation and Manufacturing Centre at the University of Sheffield, has been awarded the prestigious "Outstanding Achievement Award" by the British Society for Gene and Cell Therapy. This accolade recognizes his significant contributions to the field of gene therapy, particularly in research and the training of future scientists. Azzouz’s career is marked by a relentless pursuit of innovative solutions to neurological diseases, positioning him as a leading figure in the translation of scientific discoveries from laboratory settings into effective clinical therapies.
With a dual role as a professor of translational neuroscience, Azzouz has dedicated his career to making laboratory breakthroughs a reality for patients. His research efforts have been focused on the SMN gene, specifically targeting it for treatments related to spinal muscular atrophy. His pioneering studies have not only demonstrated the efficacy of these gene therapies but have also laid the groundwork for subsequent human trials and the approval of new treatment options. Furthermore, Azzouz’s research extends to critical areas such as Parkinson’s disease, showcasing his broad impact on neurological health.
Commitment to Research and Mentorship
Since the onset of his career in 1997, Azzouz has successfully secured more than £34 million in funding, enabling him to spearhead groundbreaking studies in gene therapy. His leadership extends beyond individual research, as he currently oversees a collaborative network of 34 institutions and companies across Europe aimed at advancing research in this vital field. Azzouz emphasizes that the recent award is not solely a personal achievement but rather a testament to the hard work of his entire team, reflecting years of collaborative effort in pushing the boundaries of science.
In addition to his research endeavors, Azzouz is deeply committed to nurturing the next generation of scientists. Over nearly three decades, he has supervised 81 researchers, including 20 PhD students, fostering an environment of learning and innovation. His entrepreneurial spirit is evident in his founding of BlackfinBio and co-founding of Crucible Therapeutics. He also plays a significant role in leading a €25.5 million European consortium aimed at accelerating the development of advanced therapies, further solidifying his influence in the field.
Expressing his optimism regarding Morocco’s scientific landscape, Azzouz highlights the country's "enormous potential" and the evolution of its research ecosystem, which includes promising institutions like the university in Benguerir. His vision for the future underlines a commitment not only to scientific advancement but also to the empowerment of young researchers in Morocco.
As reported by en.yabiladi.com.
